Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. - Wikidata - awgldk - TriplyDB

Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.

Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.

http://www.wikidata.org/entity/Q34035670

about

How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction Microtissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D Microenvironment In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'Stem cell imaging: from bench to bedside Remodelling the extracellular matrix in development and disease Decellularized matrices for cardiovascular tissue engineering Immunobiology of fibrin-based engineered heart tissue Solid organ fabrication: comparison of decellularization to 3D bioprinting Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative Medicine Bioengineering Human Myocardium on Native Extracellular Matrix.Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition Molecular assessment of collagen denaturation in decellularized tissues using a collagen hybridizing peptide Use of myocardial matrix in a chitosan-based full-thickness heart patch Human versus porcine tissue sourcing for an injectable myocardial matrix hydrogel.Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair.Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress.Extracellular matrix hydrogels from decellularized tissues: Structure and function.Cardiac extracellular matrix-fibrin hybrid scaffolds with tunable properties for cardiovascular tissue engineering Injectable microsphere gel progressively improves global ventricular function, regional contractile strain, and mitral regurgitation after myocardial infarction.Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction Macrophage polarization in response to ECM coated polypropylene mesh.Injectable ECM scaffolds for cardiac repair Anisotropic silk biomaterials containing cardiac extracellular matrix for cardiac tissue engineering.Biomaterial based cardiac tissue engineering and its applications Partially Digested Adult Cardiac Extracellular Matrix Promotes Cardiomyocyte Proliferation In Vitro.Fabrication and characterization of injectable hydrogels derived from decellularized skeletal and cardiac muscle.Extracellular Matrix Hydrogel Promotes Tissue Remodeling, Arteriogenesis, and Perfusion in a Rat Hindlimb Ischemia Model.Tailoring material properties of cardiac matrix hydrogels to induce endothelial differentiation of human mesenchymal stem cells.Electrical and mechanical stimulation of cardiac cells and tissue constructs.Quantification of decellularized human myocardial matrix: A comparison of six patients Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction Intramyocardial injection of hydrogel with high interstitial spread does not impact action potential propagation Nanocomposite hydrogels: an emerging biomimetic platform for myocardial therapy and tissue engineering.Preparation and characterization of a biologic scaffold from esophageal mucosa Modulating In Vivo Degradation Rate of Injectable Extracellular Matrix Hydrogels Stimulation of adipogenesis of adult adipose-derived stem cells using substrates that mimic the stiffness of adipose tissue.Materials science and tissue engineering: repairing the heart.Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs.

P2860

Q26739723-79090DB5-081D-49F5-A22C-B6988E4D34EB Q26748747-DFBBB1DB-FDF6-4EBA-9998-53AF004D177C Q26775715-3F931061-2AAD-4614-8DD7-8D227FDD42EC Q26861615-9FF70D01-C030-43F6-AEFC-755A0E8FDD66 Q26864798-8BF6AA35-1B0E-478E-9064-B1DA57BE9369 Q27011803-F0354CFA-F561-410D-B08B-2701C30D171B Q27301288-B0AB309B-FA62-4B1B-A164-D7ADF64B97F9 Q28077142-7E82E15C-BF01-4551-A82D-6AB733E105DC Q30390768-8AC078BE-FCDB-4312-95D7-C8107CE44EFD Q30706278-24A636B9-04E7-4303-9CD2-816B8744028C Q33650887-A2E1B765-5204-43FB-B797-AB6BEAC4D754 Q33773311-60DD84A2-6BDE-4668-9ED1-80E7B7CD3248 Q33862440-3E038ABE-95FA-46A3-9186-E84854D38210 Q34040196-7093D5F3-3053-4E9A-8E92-7FB64A373180 Q34046358-2DD6341F-57C7-4D65-9808-559BF7E1D3E1 Q34104323-C44E0FEA-716C-4E67-A8D9-58B67B728552 Q34109419-2220AD04-8B07-4794-A99F-BE14A6E595B7 Q34546589-44C4D499-4557-4F8A-B14A-70D09D786F5E Q35019955-75688557-935E-4C9A-9403-6F0E9DBE83C3 Q35039708-097B1F0C-298F-46C9-9E5D-E101B4D174D6 Q35078379-32180714-2682-42E7-BD06-3399F5E6F762 Q35141561-393ADDD9-77DC-4689-A384-81FFA75A3048 Q35219353-06F53BC9-43FE-4A0F-9E56-8C315847B2C5 Q35562754-32AF1036-EC0F-411F-9C84-652F486A1F9E Q35731251-4E8BCE13-AEA2-41B0-A5F5-EA5ED42A48EF Q35858522-0D8027E0-FF8D-4604-8332-A91B2A3A45F5 Q35920945-2747E5C1-63E9-4CB7-A90C-1F76668DC9B5 Q35996757-BA0DED7A-CF23-4F6F-9826-E590D8822E48 Q36384613-6DEF2A7B-250D-4216-BA83-A8EE3FB7D32A Q36421781-6B02095C-E83B-44A4-8BCF-3E400A2CEDE6 Q36436938-FF1B1E88-058A-4E4E-8E0D-C69372FE2825 Q36581739-30DE497C-83B5-4464-A080-DD4CCC54A8A0 Q36635288-C311C414-9522-4640-B318-C76CF1F6F8BB Q36861998-9ECE3F3F-4725-4370-9C0D-0C2BDB895642 Q37055796-32239565-01BF-4D83-8F0B-B7BB276E6947 Q37194415-933D0ACC-6C62-492B-9344-88AFE2A63129 Q37206807-282E6FB1-6C7D-4D8A-93D2-CBAC055A620C Q37206811-BAF14973-3BDA-4E3D-AE83-E940F1976EB6 Q37275869-693BA08C-F46A-4149-B38A-7CAF4CED348F Q37513850-A37839C5-10D9-49C4-9D8B-E51D73524636

P2860

Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.

http://www.wikidata.org/entity/Q34035670

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Safety and efficacy of an inje ...... reating myocardial infarction.

@ast

Safety and efficacy of an inje ...... reating myocardial infarction.

@en

Safety and efficacy of an inje ...... reating myocardial infarction.

@nl

type

label

Safety and efficacy of an inje ...... reating myocardial infarction.

@ast

Safety and efficacy of an inje ...... reating myocardial infarction.

@en

Safety and efficacy of an inje ...... reating myocardial infarction.

@nl

prefLabel

Safety and efficacy of an inje ...... reating myocardial infarction.

@ast

Safety and efficacy of an inje ...... reating myocardial infarction.

@en

Safety and efficacy of an inje ...... reating myocardial infarction.

@nl

P1433

Q34035670-7A509457-868F-465B-B253-BDE1D3FD4D2C

P1476

Q34035670-DBA154CB-754A-40F9-8A5B-67BBFBE06569

P2093

Q34035670-041C3CD2-396A-404D-A9FA-6ADC4282C6A5

Q34035670-0CBBCB32-E8D7-48C7-916D-E60919D67A32

Q34035670-1E90DE22-8A80-47D2-9F01-282CA8EB91FF

Q34035670-40242221-CC73-4AAB-95F0-FDB43365A034

Q34035670-5E2EB03E-FD14-41B5-AC82-25A5C58F89E6

Q34035670-60F16453-9CF6-4F02-9F8F-C16E5CA76C40

Q34035670-78206E84-9FCD-4546-BCA4-A7677C7750DB

Q34035670-78F29CD6-F8F5-4728-A9B4-7167C96CC741

Q34035670-93300A15-FC0F-4C5E-849A-2214DEBC8431

Q34035670-B0E4B99F-0764-43E3-AC1C-F3331DBF8B60

P2860

Q34035670-054DCF63-C356-4085-B0BC-17C2BDA583F4

Q34035670-0827FDB0-47A7-464A-ADAB-E2DAC08445FB

Q34035670-0A08DAC7-371B-443B-96D3-911C3B836603

Q34035670-193B7BD8-AEB7-4880-A00E-8C5BC17DCBA2

Q34035670-1E1FCBEA-5C0B-4393-BE59-B0BDF3DF207B

Q34035670-1E5D8132-7B09-4EE7-9D85-1FD61ADFBD2E

Q34035670-1F79AAD6-E6BA-452F-81BA-6A2F8900D79E

Q34035670-2FFC0F41-FC85-4E8B-B600-9FD9B22D49F0

Q34035670-3835C4E3-1943-4AFC-97B3-C4C1B679F08E

Q34035670-3FB2BC9B-98C4-4CFB-965B-DD88BBAC7847

P304

Q34035670-73AB3361-B715-4D55-9463-6751218D80AA

P31

Q34035670-E9D4AF14-FE18-4626-A476-6469A493C35D

P356

Q34035670-85792F6B-DFB9-475F-B3F9-19B3A8FD7A18

P407

Q34035670-72BA2940-FE26-4D1B-BE8C-E5E4F0C4BA50

P433

Q34035670-0A9FF9FC-A9AD-4268-AE80-E81D126FF79A

P478

Q34035670-622C9201-785D-435B-8CB8-D9E7F23F9A9E

P50

Q34035670-E3913AB0-9B18-49F4-9893-5AC1FB0C198E

P577

Q34035670-A6A1BABE-E794-41EA-838E-D37D3BC373B3

P698

Q34035670-76D9F011-43F2-466F-B4F8-CF03EDCB2595

P921

Q34035670-89560302-6BCC-416B-9B2C-0EDD086080EB

Q34035670-A5C5FF3A-A31F-4E02-AB7D-845B19926CB8

Q34035670-B97D832C-53C5-4FAF-8DE7-B104CC9F9081

P932

Q34035670-8EFC0CE7-F67B-471F-9E75-CDFB4A99E410

P356

SCITRANSLMED.3005503

P1433

Science Translational Medicine

P1476

Safety and efficacy of an inje ...... reating myocardial infarction.

@en

P2093

Adam M Kinsey

http://www.w3.org/2001/XMLSchema#string

Anthony N DeMaria

http://www.w3.org/2001/XMLSchema#string

G Monet Strachan

http://www.w3.org/2001/XMLSchema#string

Jean J Wang

http://www.w3.org/2001/XMLSchema#string

Jennifer M Singelyn

http://www.w3.org/2001/XMLSchema#string

Jessica A DeQuach

http://www.w3.org/2001/XMLSchema#string

Jonathan Wong

http://www.w3.org/2001/XMLSchema#string

Karen L Christman

http://www.w3.org/2001/XMLSchema#string

Kendra Bartels

http://www.w3.org/2001/XMLSchema#string

Kent G Osborn

http://www.w3.org/2001/XMLSchema#string

P2860

Biomaterials for the Treatment of Myocardial Infarction

Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: data from the Heart and Soul Study.

Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component.

Simple and high yielding method for preparing tissue specific extracellular matrix coatings for cell culture

Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium

Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model

Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage.

Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges.

P304

173ra25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3005503

http://www.w3.org/2001/XMLSchema#string

P407

P433

173

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23427245

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

P932

3848875

http://www.w3.org/2001/XMLSchema#string